U09.9GPOSTCOVID19ZUSTANDNICHTNHERBEZEICHNETU10.9GMULTISYSTEMISCHESENTZNDUNGSSYNDROMINVERBINDUNGMITCOVID19NICHTNHERBEZEICHNET COVID19VIRUSNACHGEWIESEN U07.1 U09.9
Conditions
Interventions
Group 1: Group 1 PIMS/MIS-C: Questionnaire, EndoPAT examination, SDF examination, blood and urin samples (acute, after 3-6 months, after 12 months)
Group 2: Group 2 Long Covid: : Questionnaire, EndoP
Sponsors
Klinikum der Universität München, Campus Großhadern
Eligibility
Sex/Gender
All
Age
6 Years to 18 Years
Inclusion criteria
Inclusion criteria: Patients with the following criteria should be included: - Patients with positive SARS-CoV-2 serology or diagnosis of an acute Covid-19 disease - Patients diagnosed with PIMS/MIS-C - Patients diagnosed with Long Covid Healthy controls without SARS-CoV-2 infection should be included.
Exclusion criteria
Exclusion criteria: The exclusion criteria include the lack of consent to participate in the study and the revocation of consent. The healthy control patients must be free of infection, and they must not have any underlying cardiovascular diseases, including all diseases that affect the cardiovascular system, e.g. diabetes mellitus, underlying oncological diseases and neuromuscular diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| We hope that the investigations will contribute to a better understanding of the pathogenesis of SARS-CoV-2, especially MIS-C/PIMS and Long Covid. | — |
Secondary
| Measure | Time frame |
|---|---|
| Furthermore we hope to generate starting points for prevention, therapy and prognosis. | — |
Countries
Germany
Contacts
Public ContactJulie Boever
Klinikum der Universität München, Campus Großhadern
Outcome results
None listed